Apollo Hospitals (APOLLOHOSP) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
13 Jun, 2025India's largest integrated healthcare system
Operates 73 hospitals with 10,138 beds and over 10,000 doctors, plus India's largest offline pharmacy network with 6,000+ stores in 1,200+ cities and towns.
Extensive retail healthcare network: 264 primary clinics, 183 dental clinics, 72 sugar clinics, 31 birthing centers, 133 dialysis centers, 22 surgery centers, and 2,203 diagnostic collection centers.
Recognized for clinical innovation, digital transformation, and a patient-centric, outcomes-driven care model.
Built a trusted brand synonymous with quality, supported by significant government recognition and successful partnerships.
Created unmatched consumer insights and shareholder value, with a 6x increase in market capitalization over the last decade.
Financial and operational performance
FY24 consolidated revenue reached $2.29 billion, with a 16% CAGR since FY13; healthcare services and pharmacy segments grew at 14% and 20% CAGR, respectively.
Q2FY25 consolidated revenue grew 15% YoY to 55,893 mio, EBITDA up 30% to 8,155 mio, and PAT up 63% to 3,788 mio.
H1FY25 consolidated revenue rose 15% YoY to 106,749 mio, EBITDA up 31% to 14,906 mio, and PAT up 71% to 6,840 mio.
Healthcare services maintained strong margins (24.9% in Q2FY25), with occupancy at 73% and ARPOB up 3% YoY.
Return on capital employed (ROCE) for healthcare services at 26.1% and pharmacy distribution at 31.5% as of March 2024.
Segment highlights and expansion
Apollo Health & Lifestyle Ltd (AHLL) revenue grew 14% YoY in Q2FY25, with diagnostics and specialty care showing strong margin improvements.
Apollo HealthCo (omnichannel pharmacy) revenue grew 17% YoY in Q2FY25, with PAT turning positive due to cost optimization and operational growth.
Advent International invested INR 1,732 crs in Apollo HealthCo, with a phased merger of Keimed to create India's leading integrated pharmacy distribution business.
Expansion plans include new hospitals and brownfield projects in major metros and Tier 1 cities, targeting over 3,500 new beds in the next 3-4 years.
Digital platform Apollo 24/7 serves 36 million+ registered users, with 6,228 pharmacies and 14,500+ daily virtual consultations.
Latest events from Apollo Hospitals
- Q3 FY26 saw 17% revenue and 35% PAT growth, with expansion and a Rs.10 interim dividend.APOLLOHOSP
Q3 25/2611 Feb 2026 - 15% revenue growth, 33% EBITDA rise, and 83% PAT surge, with digital and pharmacy expansion.APOLLOHOSP
Q1 24/252 Feb 2026 - Q2 FY25 delivered 15% revenue and 63% PAT growth, with robust expansion and digital momentum.APOLLOHOSP
Q2 24/2516 Jan 2026 - Q3 FY25 delivered 14% revenue and 52% PAT growth, with digital and specialty gains.APOLLOHOSP
Q3 24/258 Jan 2026 - Q1 FY26 saw 15% revenue, 26% EBITDA, and 42% PAT growth, with strong digital momentum.APOLLOHOSP
Q1 25/2623 Nov 2025 - FY25 revenue up 14% YoY, PAT up 61%, with major expansion and INR 19/share dividend.APOLLOHOSP
Q4 24/2519 Nov 2025 - Q2 FY26 revenue up 13% YoY, EBITDA up 15%, PAT up 26%, with major expansion and digital plans.APOLLOHOSP
Q2 20267 Nov 2025 - Equity infusion and merger set to create India's top integrated pharmacy and digital health platform.APOLLOHOSP
Transaction Rationale, Valuation and Governance Presentation16 Jun 2025